• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multiple sclerosis: severe exacerbation after stopping disease-modifying drugs.

作者信息

Członkowska A, Mirowska-Guzel D

机构信息

2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw.

Chair and Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland.

出版信息

Eur J Neurol. 2018 Oct;25(10):1199-1200. doi: 10.1111/ene.13746. Epub 2018 Jul 20.

DOI:10.1111/ene.13746
PMID:29959813
Abstract
摘要

相似文献

1
Multiple sclerosis: severe exacerbation after stopping disease-modifying drugs.多发性硬化症：停用疾病修正药物后严重恶化。
Eur J Neurol. 2018 Oct;25(10):1199-1200. doi: 10.1111/ene.13746. Epub 2018 Jul 20.
2
Disease Exacerbation after the Cessation of Fingolimod Treatment in Japanese Patients with Multiple Sclerosis.日本多发性硬化症患者停用芬戈莫德治疗后的疾病恶化
Intern Med. 2018 Sep 15;57(18):2647-2655. doi: 10.2169/internalmedicine.0793-18. Epub 2018 Apr 27.
3
Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumab.从芬戈莫德转换为阿仑单抗后出现意外的多发性硬化症活动。
Mult Scler Relat Disord. 2018 Oct;25:216-218. doi: 10.1016/j.msard.2018.08.006. Epub 2018 Aug 7.
4
Severe disease exacerbations in patients with multiple sclerosis after discontinuing fingolimod.停用芬戈莫德后多发性硬化症患者的严重疾病加重
Neurol Neurochir Pol. 2017 Mar-Apr;51(2):156-162. doi: 10.1016/j.pjnns.2017.01.006. Epub 2017 Feb 2.
5
The 'Field Hypothesis': rebound activity after stopping disease-modifying therapies.“场假说”：停止疾病修饰治疗后的反弹活动。
Mult Scler Relat Disord. 2017 Jul;15:A1-A2. doi: 10.1016/j.msard.2017.06.005.
6
Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis.多发性硬化症患者停用芬戈莫德治疗后的严重反弹。
Mult Scler Relat Disord. 2017 Jan;11:1-3. doi: 10.1016/j.msard.2016.11.003. Epub 2016 Nov 11.
7
Cutaneous cryptococcosis in a patient taking fingolimod for multiple sclerosis: Here come the opportunistic infections?一名服用芬戈莫德治疗多发性硬化症的患者发生皮肤隐球菌病：机会性感染会接踵而至吗？
Mult Scler. 2017 Feb;23(2):297-299. doi: 10.1177/1352458516670732.
8
Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis.从那他珠单抗转换为芬戈莫德时缩短冲洗期至 4 周与多发性硬化症疾病再激活的风险。
Mult Scler Relat Disord. 2018 Oct;25:14-20. doi: 10.1016/j.msard.2018.07.005. Epub 2018 Jul 6.
9
Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.芬戈莫德停药后多发性硬化症的反弹综合征
JAMA Neurol. 2016 Nov 1;73(11):1375-1376. doi: 10.1001/jamaneurol.2016.3507.
10
Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.芬戈莫德停药后多发性硬化症的反弹综合征
JAMA Neurol. 2016 Nov 1;73(11):1375. doi: 10.1001/jamaneurol.2016.3199.

引用本文的文献

1
Rebound effect, discontinuation, and withdrawal syndromes associated with drugs used in psychiatric and neurological disorders.与精神和神经疾病用药相关的反跳效应、停药反应及戒断综合征。
Pharmacol Rep. 2025 Apr;77(2):303-314. doi: 10.1007/s43440-024-00689-z. Epub 2024 Dec 23.
2
Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers.病例报告：多发性硬化症患者在接受第二次阿仑单抗治疗后出现肿块样脱髓鞘病变；免疫细胞特征和生物标志物。
Front Immunol. 2024 Jul 3;15:1395749. doi: 10.3389/fimmu.2024.1395749. eCollection 2024.